Panjang
Ready for reverse move
As Peter Lynch said "buy companies that are hated by public"
Touched the bottom of downward channel. Upcoming PDUFA can affect the stock price in a negative way and push it to $1 (or even down below a bit).
The company has a huge debt and it is priced as BK company but it has great pipeline and it has all the chances to get a decent deal on opioid case. In such a case it will skyrocket. The issues are the same as they were when the stock price was $80. In case if opioid deal settled company capitalization will be 10 times higher at least. Drivers for further revenue growth: Terlipressin, Stratagraft, iNO. For now, valuation of the company is ridiculous.
Be aware it is very high risk game. Kind of binary game.
Touched the bottom of downward channel. Upcoming PDUFA can affect the stock price in a negative way and push it to $1 (or even down below a bit).
The company has a huge debt and it is priced as BK company but it has great pipeline and it has all the chances to get a decent deal on opioid case. In such a case it will skyrocket. The issues are the same as they were when the stock price was $80. In case if opioid deal settled company capitalization will be 10 times higher at least. Drivers for further revenue growth: Terlipressin, Stratagraft, iNO. For now, valuation of the company is ridiculous.
Be aware it is very high risk game. Kind of binary game.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.